Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
The lipid panel testing market has experienced substantial growth over recent years, driven by increasing health concerns and advancements in diagnostic technologies. As the importance of monitoring lipid levels becomes more recognized, the market is set to continue expanding with promising opportunities on the horizon. Let’s explore the current market size, key growth drivers, segmentation, evolving trends, leading players, and regional developments shaping this industry.
Steady Expansion in Lipid Panel Testing Market Size and Projections
The lipid panel testing market has shown strong growth, with its value rising from $11.61 billion in 2025 to a projected $12.61 billion in 2026, marking a compound annual growth rate (CAGR) of 8.6%. This upward trajectory is linked to factors such as the growing prevalence of cardiovascular diseases, expansion of routine health screenings, heightened awareness about cholesterol control, wider adoption of automated laboratory diagnostics, and improved access to testing services. Looking ahead, the market is anticipated to reach $17.79 billion by 2030, growing at a CAGR of 9.0%. This expected growth is supported by increased emphasis on preventive healthcare, rising demand for home diagnostic options, integration of digital health technologies, expanding use of AI-driven diagnostic tools, and broader population health screening programs.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10270&type=smp
Key Factors Supporting Growth in the Lipid Panel Testing Market
One of the primary reasons behind the market’s expansion is the rising occurrence of cardiovascular and diabetic conditions globally. Cardiovascular diseases, which affect the heart and blood vessels, along with diabetes characterized by high blood sugar levels, contribute significantly to lipid abnormalities. This makes lipid panel testing a crucial tool for early diagnosis, risk evaluation, treatment planning, and ongoing patient management. By identifying dyslipidemia, healthcare providers can tailor therapies and help reduce the risk of severe complications such as heart attacks and strokes.
Supporting this trend, data released by the American College of Cardiology in September 2025 indicated that deaths related to cardiovascular diseases reached 19.2 million worldwide in 2023. This growing health burden emphasizes the importance of lipid testing in managing patient outcomes, thereby propelling the market’s demand.
Access The Complete Lipid Panel Testing Market Report:
https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report
Breaking Down the Lipid Panel Testing Market Segments
The market is categorized into several key segments for better analysis. These include:
1) Product and Services: Devices, Kits, and Services
2) Prescription Mode: Prescription-Based Testing and Over-the-Counter (OTC) Testing
3) Application Areas: Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hypo-Lipoproteinemia, Tangier Disease, Atherosclerosis, and other uses
4) End Users: Hospitals, Specialty Clinics and Physician Offices, Pathology Laboratories, Diagnostic Clinics, Reference Laboratories, Academic and Research Institutes, along with other end users.
Further subcategories under devices consist of automated analyzers, point-of-care testing devices, and spectrophotometers. Kits include cholesterol, HDL and LDL, and triglyceride test kits, while the services segment covers laboratory testing, diagnostic, and health screening services.
Innovative Trends Reshaping the Lipid Panel Testing Market
Leading companies are increasingly investing in advanced diagnostic solutions to improve cardiovascular risk assessment. A notable development is the introduction of Lp(a)-based diagnostic assays, which measure lipoprotein(a) levels in the blood. These assays provide clinicians with actionable insights to identify patients at higher cardiovascular risk and enable more personalized treatment plans.
For example, in May 2024, F. Hoffmann-La Roche AG launched the Tina-quant Lp(a) RxDx assay after securing the FDA Breakthrough Device Designation. This test quantifies the number of Lp(a) molecules per litre in the bloodstream, offering a standardized biomarker for cardiovascular risk. Seamlessly integrated into Roche’s serum work area systems and cobas® platforms, it supports healthcare professionals in making informed decisions about Lp(a)-lowering therapies, ultimately enhancing patient care and precision medicine in cardiovascular health.
Leading Players in the Lipid Panel Testing Market
The lipid panel testing landscape features several prominent companies including Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH, Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., EKF Diagnostics Holdings plc, and Ortho Clinical Diagnostics LLC.
Regional Market Insights Highlighting Growth Leaders
North America was the top revenue-generating region in the lipid panel testing market as of 2025. Meanwhile, the Asia-Pacific region is projected to register the fastest growth during the forecast period. The market report covers several major regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive picture of global market trends and opportunities.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
